(UroToday.com) The joint session of the European Association of Urology EAU and the Confederacion Americana de Urologia included a session discussing the surgical treatment of lymph node recurrences after radical prostatectomy. Dr. Nicola Fossati from San Raffaele, Milan took the pro surgery approach for his presentation.
(UroToday.com) Dr. Karim Fizazi presents the results of the PEACE-1 randomized phase 3 clinical trial with a focus on the impact of adding abiraterone acetate + prednisone to ADT+docetaxel on radiographic progression-free survival (rPFS) during this session at the 2021 European Association of Urology, (EAU) annual meeting. The results of the PEACE-1 randomized phase 3 clinical […]
(UroToday.com) The joint session of the European Association of Urology (EAU) and the Canadian Urological Association at the 2021 EAU annual meeting included a discussion on PSA, Imaging and Beyond for assessing men for prostate biopsy and a presentation by Dr. Nicolas Mottet about keeping the process simple. Dr. Mottet notes that an indication for biopsy […]
(UroToday.com) The joint session of the European Association of Urology (EAU) and the Canadian Urological Association (CUA) included a presentation by Dr. Antonio Finelli discussing the importance of making indications for prostate biopsy as precise as possible. Dr. Finelli notes that the question of who and how we should biopsy men is a difficult question to […]
(UroToday.com) Following the presentation by Dr. Karim Fizazi on the phase 3 PEACE-1 trial. Dr. Axel Heidenreich provides a discussion presentation on important considerations for interpretation of this trial. The PEACE-1 phase 3 trial studied abiraterone acetate plus prednisone added to androgen deprivation therapy and docetaxel in men with de novo metastatic castration-sensitive prostate cancer (mCSPC).
(UroToday.com) The joint session of the European Association of Urology and the Maghreb Union Countries included a presentation by Dr. Imad Ziouziou who discussed the preparation of patients for radical cystectomy. Dr. Ziouziou started by noting that radical cystectomy plus extended pelvic lymphadenectomy is the gold standard treatment for muscle invasive bladder cancer and for those […]
(UroToday.com) Dr. Wassim Kassouf discussed avoiding deviation from the guidelines for BCG maintenance therapy for the sake of patient’s safety at the 2021 European Association Urology (EAU) annual meeting’s joint session between the EAU and Canadian Urological Association (CUA). Dr. Kassouf emphasized that many of his recommendations will be based on the new CUA Guidelines on […]
(UroToday.com) The Canadian Urological Association joint session with the European Association Urology (EAU) at the 2021 annual EAU virtual meeting included a presentation by Dr. J. Alfred Witjes who discussed shorter maintenance regimens for patients receiving BCG therapy. When the guidelines discuss BCG “and/or alternative treatments”, this is an issue for patients with higher-end intermediate-risk NMIBC, […]
In this broadcast of EAU TV, Prof. Peter Albers (DE) and Prof. James N’Dow (GB) each host a section to discuss the highlights of one specific topic on this Congress day. Today’s topics are Prostate Cancer and Incontinence & Andrology. The panellists are Prof. Dr. Nicolas Mottet (FR), Prof. Dr. Monique Roobol (NL), Prof. Jens Sønksen (DK), and Prof. Francisco […]
High rates of overdiagnosis are a critical barrier to organized prostate cancer screening. Magnetic resonance imaging (MRI) with targeted biopsy has shown the potential to address this challenge, but the implications of its use in the context of organized prostate cancer screening are unknown.
